New research at Washington University School of Medicine in St. Louis indicates that three new, fast-spreading variants of the virus that cause COVID-19 can evade antibodies that work against the original form of the virus that sparked the pandemic. With few exceptions, whether such antibodies were produced in response to...
Full ArticleNew Evidence COVID-19 Antibodies, Vaccines Less Effective Against Variants
Eurasia Review
0 shares
2 views
You might like
Related news coverage
When Will Kids Have A Covid-19 Vaccine?
Newsy
Watch VideoResearchers test vaccines in adults first, then typically move down the age brackets and that includes Moderna and..
The United Nations In The Fight Against Covid – Analysis
Eurasia Review
Advertisement
More coverage
Tiziana Life Sciences planning phase II clinical trial of monoclonal antibody treatment in patients with moderate to severe COVID-19
Proactive Investors
Tiziana Life Sciences PLC (NASDAQ:TLSA, LON:TILS) is taking its nasally-administered monoclonal antibody (mAB) into phase II..
-
Tiziana Life Sciences plans phase II trials of nasal antibody treatment in COVID-19 patients
Proactive Investors
-
COVID vaccine found highly effective in real-world US study
SeattlePI.com
-
COVID-19: Analysis of the sensitivity of the UK (B.1.1.7) and South African (B.1.351) variants to SARS-CoV-2 neutralizing antibodies
Science Daily
-
Pregnant women show robust immune response to COVID vaccines, pass antibodies to newborns
Science Daily